Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,804,234
-$263,921 QoQ
Shares Held
300,561
-1.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#95
of 639 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MANNING & NAPIER ADVISORS LLC holds $28,794,500 across 9 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,425,546 | $22,637,670 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
206,900 | $3,316,607 | |
| 3 | HLN |
Haleon plc
This page
|
300,561 | $2,804,234 | |
| 4 | ZTS |
Zoetis Inc.
|
239 | $17,174 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
55 | $9,269 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
7 | $3,792 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
86 | $2,913 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
38 | $1,767 |
All Filings in HLN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,804,234 | 300,561 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,068,155 | 306,509 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,142,754 | 310,856 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,869,700 | 319,922 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,594,210 | 346,597 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,326,304 | 323,256 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $3,158,245 | 331,053 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,624,813 | 342,610 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,833,353 | 343,021 | Shares | Sole | 2024-07-11 | |
| No filing history on record for this holder in this stock. | ||||||